Pyrroloquinoline Quinone Alleviates Age-Related Osteoarthritis Via Nuclear Factor Erythroid 2-Related Factor 2-Mediated Stress Response And Insulin-Like Growth Factor 1 Receptor Upregulation
Osteoarthritis (OA) is a common and debilitating joint disease, particularly as we age, characterized by the breakdown of cartilage and underlying bone. This condition often stems from accumulated cellular damage, aging cells, and the gradual loss of the protective tissue in our joints. Current treatments often manage symptoms but don’t halt the disease’s progression.
Recent research has shed light on a promising natural compound called pyrroloquinoline quinone, or PQQ. PQQ is known for its powerful antioxidant properties, meaning it helps protect cells from damage caused by harmful molecules. A study investigating its effects on age-related OA in mice showed remarkable results: long-term dietary PQQ significantly reduced the severity of OA, preserving the structure of cartilage and bone, and decreasing inflammation in the joints.
The mechanism behind PQQ’s protective effects involves a crucial protein in our bodies called Nrf2. Nrf2 acts like a master switch, turning on genes that help our cells defend against stress and damage. The research found that PQQ activates Nrf2, which then leads to an increase in the insulin-like growth factor 1 receptor (IGF-1R). IGF-1R is vital for the health and maintenance of cartilage, promoting its growth and repair. This newly identified pathway, involving PQQ, Nrf2, and IGF-1R, suggests a potential new strategy for developing therapies to prevent or slow the progression of age-related osteoarthritis.
Source: link to paper